These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22554311)

  • 21. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group.
    Brent J; McMartin K; Phillips S; Burkhart KK; Donovan JW; Wells M; Kulig K
    N Engl J Med; 1999 Mar; 340(11):832-8. PubMed ID: 10080845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidote review: fomepizole for methanol poisoning.
    Mycyk MB; Leikin JB
    Am J Ther; 2003; 10(1):68-70. PubMed ID: 12522524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of methanol and isopropanol poisoning with intravenous fomepizole.
    Bekka R; Borron SW; Astier A; Sandouk P; Bismuth C; Baud FJ
    J Toxicol Clin Toxicol; 2001; 39(1):59-67. PubMed ID: 11327228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Severe ethylene glycol poisoning treated wtih fomepizole (4-methylpyrazole)].
    Aakervik O; Svendsen J; Jacobsen D
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2444-6. PubMed ID: 12448112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethylene glycol poisoning in a child treated with 4-methylpyrazole.
    Harry P; Jobard E; Briand M; Caubet A; Turcant A
    Pediatrics; 1998 Sep; 102(3):E31. PubMed ID: 9724679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicokinetics of ethylene glycol during fomepizole therapy: Implications for management.
    Sivilotti MLA; Burns MJ; McMartin KE; Brent J;
    Ann Emerg Med; 2000 Aug; 36(2):114-125. PubMed ID: 33291207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Methylpyrazole and hemodialysis in ethylene glycol poisoning.
    Jobard E; Harry P; Turcant A; Roy PM; Allain P
    J Toxicol Clin Toxicol; 1996; 34(4):373-7. PubMed ID: 8699550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute methanol poisoning with fomepizole.
    Mégarbane B; Borron SW; Trout H; Hantson P; Jaeger A; Krencker E; Bismuth C; Baud FJ
    Intensive Care Med; 2001 Aug; 27(8):1370-8. PubMed ID: 11511951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fomepizole for the treatment of methanol poisoning.
    Brent J; McMartin K; Phillips S; Aaron C; Kulig K;
    N Engl J Med; 2001 Feb; 344(6):424-9. PubMed ID: 11172179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of high-dose fomepizole compared with ethanol as therapy for ethylene glycol intoxication in cats.
    Connally HE; Thrall MA; Hamar DW
    J Vet Emerg Crit Care (San Antonio); 2010 Apr; 20(2):191-206. PubMed ID: 20487247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradycardia and hypotension associated with fomepizole infusion during hemodialysis.
    Lepik KJ; Brubacher JR; DeWitt CR; Lam GS; Lawson EJ; Erhardt GD; Purssell RA; Kennedy JR; Brignall JL
    Clin Toxicol (Phila); 2008 Jul; 46(6):570-3. PubMed ID: 18584373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients.
    Faessel H; Houze P; Baud FJ; Scherrmann JM
    Eur J Clin Pharmacol; 1995; 49(3):211-3. PubMed ID: 8665997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral fomepizole administration to treat ethylene glycol and methanol poisonings: advantages and limitations.
    Mégarbane B; Houzé P; Baud FJ
    Clin Toxicol (Phila); 2008 Dec; 46(10):1097; author reply 1097-8. PubMed ID: 18763149
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of a 1,4-butanediol poisoning with fomepizole.
    Mégarbane B; Fompeydie D; Garnier R; Baud FJ
    J Toxicol Clin Toxicol; 2002; 40(1):77-80. PubMed ID: 11990207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance with poison center fomepizole recommendations is suboptimal in cases of toxic alcohol poisoning.
    Mycyk MB; DesLauriers C; Metz J; Wills B; Mazor SS
    Am J Ther; 2006; 13(6):485-9. PubMed ID: 17122528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current management of ethylene glycol poisoning.
    Brent J
    Drugs; 2001; 61(7):979-88. PubMed ID: 11434452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethylene glycol or methanol intoxication: which antidote should be used, fomepizole or ethanol?
    Rietjens SJ; de Lange DW; Meulenbelt J
    Neth J Med; 2014 Feb; 72(2):73-9. PubMed ID: 24659589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethylene glycol elimination kinetics and outcomes in patients managed without hemodialysis.
    Levine M; Curry SC; Ruha AM; Pizon AF; Boyer E; Burns J; Bikin D; Gerkin RD
    Ann Emerg Med; 2012 Jun; 59(6):527-31. PubMed ID: 22226175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.